izpis_h1_title_alt

Sinteza novih zaviralcev encima MurA iz glukozamina: primerjava učinkovitosti različnih sinteznih poti
ID Kampl, Klemen (Avtor), ID Frlan, Rok (Mentor) Več o mentorju... Povezava se odpre v novem oknu

.pdfPDF - Predstavitvena datoteka, prenos (1,59 MB)
MD5: 6EED6EA7C656924B160917E7565220AC

Izvleček
Naraščajoča odpornost bakterij proti antibiotikom predstavlja vse bolj akuten izziv za globalni zdravstveni sistem, saj mnoge prej ozdravljive okužbe postajajo manj ozdravljive ali celo neobvladljive. Svetovna zdravstvena organizacija (WHO) je uvrstila bakterijsko odpornost proti antibiotikom med tri največje grožnje za javno zdravje v 21. stoletju. Zato je razvoj novih protimikrobnih zdravil postal ena izmed ključnih prioritet, saj je to edini način, da se izognemo eskalaciji te težave. Peptidoglikan je pomemben gradnik bakterijske celične stene, ki se sintetizira v treh različnih delih celice: v citoplazmi, celični membrani in zunaj celice. Prva stopnja reakcijske poti poteka v citoplazmi, kjer encim MurA katalizira pomemben korak. Večina trenutnih protibakterijskih zdravil zavira sintezo peptidoglikana v zadnjih stopnjah sinteze, ki potekajo izven celice. Kljub temu nekaj antibiotikov deluje znotraj celice, med njimi je fosfomicin, ki zavira aktivnost encima MurA v citoplazmi. V tej magistrski nalogi je poudarek na ustvarjanju derivatov glukozamina s pomočjo molekularnega modeliranja in simulacije naravnega substrata. Za ustrezno usmerjanje funkcionalnih skupin in izdelavo reverzibilnih zaviralcev smo za osnovo izbrali skelet glukozamina, ki lahko prodre skozi celično steno in membrano bakterij ter doseže encim MurA v njihovem notranjem okolju. Glavni cilj je bil razviti sintezno pot za pripravo potencialnih zaviralcev encima MurA, ki so modificirani s fragmenti na mestu C-6, ter atomu N-1. Osredotočili smo se na uporabo nove zaščitne skupine BDA, ki smo jo uvedli na mesti C-3 in C-4. Pred uvedbo BDA smo zaščitili amin z zaščitno skupino Cbz. Nato smo poskušali optimizirati pogoje, ter razmerje reagentov za uvedbo BDA. Ko nam sinteze v naslednjem koraku več niso uspevale, smo se odločili za opustitev BDA in se vrnili na sintezo preko uveljavljenih zaščitnih skupin (tritilna na C-6, benzilni na C-3 in C-4). Na koncu smo na mesto C-6 pripeli kloroetil acetat oz. bromometil acetet. Pri tej sintezni poti smo se osredotočili na prednosti in slabosti, ter težave, ki so se nam pojavljale.

Jezik:Slovenski jezik
Ključne besede:odpornost proti antibiotikom, peptidoglikan, zaviralec, glukozamin, encim MurA, BDA
Vrsta gradiva:Magistrsko delo/naloga
Organizacija:FFA - Fakulteta za farmacijo
Leto izida:2024
PID:20.500.12556/RUL-159323 Povezava se odpre v novem oknu
Datum objave v RUL:06.07.2024
Število ogledov:79
Število prenosov:27
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Synthesis of novel MurA enzyme inhibitors from glucosamine: comparison of the efficacy of different synthesis pathways
Izvleček:
The increasing resistance of bacteria to antibiotics poses an ever more acute challenge for the global healthcare system, as many previously treatable infections are becoming less and less curable or even uncontrollable. The World Health Organization (WHO) has classified bacterial resistance to antibiotics as one of the three greatest threats to public health in the 21st century. Therefore, the development of new antimicrobial drugs has become a top priority as it is the only way to prevent this problem from escalating. Peptidoglycan is an important component of the bacterial cell wall that is synthesized in three different parts of the cell: in the cytoplasm, in the cell membrane and outside the cell. The first stage of the reaction pathway takes place in the cytoplasm, where the enzyme MurA catalyzes an important step. Most current antibacterial drugs inhibit the synthesis of peptidoglycan in the final stages of synthesis, which take place outside the cell. However, some antibiotics act inside the cell, including fosfomycin, which inhibits the activity of the MurA enzyme in the cytoplasm. This master thesis focuses on the development of glucosamine derivatives through molecular modeling and simulation of natural substrates. For the proper targeting of functional groups and the production of reversible inhibitors, we have chosen the glucosamine skeleton as a base that can penetrate the cell wall and membrane of bacteria and reach the MurA enzyme in their internal environment.Our main goal was to develop a synthetic route for the production of potential inhibitors of the MurA enzyme modified with fragments at the C-6 and N-1 positions. We focused on the use of a new protecting group, BDA, introduced at positions C-3 and C-4. Before introducing BDA, we protected the amine with a Cbz protecting group. We then tried to optimize the conditions and ratio of reagents for the introduction of BDA. When the synthesis did not progress in the next step, we decided to abandon BDA and revert to synthesis via the established protecting groups (trityl at C-6, benzyl at C-3 and C-4). Finally, we attached chloroethyl acetate or bromomethyl acetate to the C-6 position. During this synthesis pathway, we focused on the advantages, disadvantages and challenges we encountered.

Ključne besede:antibiotic resistance, peptidoglycan, inhibitor, glucosamine, MurA, BDA

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj